Straight answers.

No. The cellular and biologic therapies Nuvira offers are not FDA-approved, and compounded peptides are not FDA-approved either. What that phrase does and doesn't tell you is a longer read.

No. Utah's law is a state licensing rule about disclosure and consent. It does not make any therapy FDA-approved, and it does not change federal law. Utah law lets a health care provider whose scope of practice includes stem cell therapy perform a stem cell therapy that is not FDA-approved, but only after giving the patient a specific written notice and obtaining a signed consent form. The longer explanation is in the library.

No. We can't promise that. Individual results vary, and no outcome is promised. What you can have is what is known, what isn't yet, the risks and the cost, in writing, before you decide.

That is yours to answer, and we won't answer it for you. Our part is to put what is known, what isn't, the risks and the cost in writing, so you can weigh it with your own doctor. “No” is a reasonable conclusion.

Every option carries risk, and some of what matters is not yet known. Both are reviewed with you before you decide and written into your plan. If any clinic tells you there is no risk, ask more questions.

Two kinds of elective program, each with one point of contact and a scheduled review around day 90. Cellular and biologic therapies are umbilical cord–derived biologic preparations, selected and administered under clinical supervision. Peptide programs are structured over 12–16 weeks and reviewed by your treating clinician. Peptides are prescribed only when your clinician judges them appropriate, and are filled through a licensed compounding pharmacy. These therapies are not FDA-approved, and candidacy is decided at consultation.

We can't tell you from a web page, and we won't guess. Candidacy is decided at consultation, once your treating clinician has reviewed your history and goals.

Then you'll be told directly, and nothing is scheduled. Being told no is part of the process, not a failure of it.

Yes. Utah's notice encourages you to talk with your primary care provider first. So do we. Your written plan is made to be handed to your own physician: Nuvira is a complement to that care, never a replacement.

One point of contact, from the first call to the day-90 review. Clinical decisions sit with your treating clinician, who reviews your plan. Ask who that is on your first call, and ask any other clinic the same. About Nuvira says more.

There is no price list, because pricing is individualized. It is discussed at your consultation, and you'll have it in writing before anything is scheduled. That includes anything related to the visit itself.

Ask us on your first call. It is a fair thing to settle early, and if it will decide things for you, ask it before anything else. Pricing is discussed at your consultation, and you'll have it in writing before anything is scheduled.

No. Keep the written plan, show it to your own doctor, and decide in your own time. Nothing is scheduled until you say yes.

No. Nuvira is based in Layton, Utah, and our clinicians come to you. A date and a place are agreed with you in advance. How visits work has the details.

At your home, where you're staying, at your office, or at a partner medical office we arrange. Which setting is appropriate is your clinician's call.

We see clients across Utah and, by arrangement, in other states. Where we can see you depends on where your treating clinician is licensed. Tell us where you are on the first call and we'll tell you plainly.

Yes. Group visits can be arranged: several people seen at one location, each with their own conversation, clinician review and written plan.

The program continues: 12–16 weeks of support with check-ins, and a scheduled review around day 90. The day-90 review is included in every program.

Your point of contact, the same one you've had since the first call. You'll reach a person, not a portal. In an emergency, call 911.

To look at where you are and decide together what, if anything, comes next. It is a review, not a renewal pitch.

That is a real possibility, and you should weigh it before you decide. Individual results vary, and no outcome is promised. We say so before you start, not after. The day-90 review is where we look at it plainly and decide together what, if anything, comes next.

Contact details only: a name and a way to reach you. Please don't send health details through the website. The privacy policy covers the rest.

No. Sending a form, taking the fit check or booking a call does not create a clinician–patient relationship, and it commits you to nothing. The fit check asks no health questions and is not a medical screening.